Barely Significant
← all excerpts

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma.

Cancers (Basel) · 2022 · PMC8909598 · PMID 35267470

1
hedged sentence
closest p
boldest claim

The sentences

may not be significantno p-value reported
However, comparison with previous trials should be done carefully as clinical characteristics differ largely between studies and differences may not be significant with this sample size.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.